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Immune activity in the central nervous system 
(CNS) is restricted, primarily because of the 
blood–brain barrier (Hickey, 1999; Pachter et al., 
2003; Carson et al., 2006; Bechmann et al., 
2007). Nevertheless, a substantial body of re-
search has addressed pro- and antiinflammatory 
cytokine activity in CNS functioning. Sickness, 
stress, depression, aging, and other somatic 
conditions  that  detrimentally  affect  cognitive 
function have been linked to an increase in the 
expression of proinflammatory cytokines and 
their receptors in different areas of the brain 
(Dantzer, 2001, 2008; Reichenberg et al., 2001; 
Kelley et al., 2003). One such area is the hip-
pocampus, which is partially responsible for 
spatial learning and memory acquisition (O’Keefe 
and Dostrovsky, 1971; Griffin et al., 2007). Cyto-
kines principally shown to have a detrimental 
effect  on  cognitive  function  include  TNF,   
IL-1, IL-6, and IL-12 (Sparkman et al., 2006; 
Baune et al., 2008; McAfoose et al., 2009). In-
nate immune cells, both peripheral and CNS 
resident, were proposed as the source of pro-
inflammatory cytokines that are secreted in   
response to any deviation from physiological 
homeostasis as a result of stress, disease, or in-
jury (Perry et al., 2007). Adaptive immunity 
has been less well studied. Interestingly, IL-4 
was shown to mediate numerous beneficial   
effects on CNS function in animal models of   
aging brain and Alzheimer’s disease (Lyons et al., 
2007;  Clarke  et  al.,  2008;  Cao  et  al.,  2009; 
Loane et al., 2009).
Studies from our own and other laborato-
ries have shown that the adaptive arm of the 
immune system plays a major role in the func-
tioning of the normal brain and regulates cog-
nitive function (Kipnis et al., 2004; Brynskikh 
et al., 2008). Specifically, we found an associ-
ation between adaptive immune deficiency and 
reduced cognitive abilities in spatial learning and 
memory tasks. When T cell–deficient mice 
were injected with splenocytes from wild-type 
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Proinflammatory cytokines have been shown to impair cognition; consequently, immune 
activity in the central nervous system was considered detrimental to cognitive function. 
Unexpectedly, however, T cells were recently shown to support learning and memory, though 
the underlying mechanism was unclear. We show that one of the steps in the cascade of  
T cell–based support of learning and memory takes place in the meningeal spaces. Perfor-
mance of cognitive tasks led to accumulation of IL-4–producing T cells in the meninges. 
Depletion of T cells from meningeal spaces skewed meningeal myeloid cells toward a proin-
flammatory phenotype. T cell–derived IL-4 was critical, as IL-4/ mice exhibited a skewed 
proinflammatory meningeal myeloid cell phenotype and cognitive deficits. Transplantation 
of IL-4/ bone marrow into irradiated wild-type recipients also resulted in cognitive 
impairment and proinflammatory skew. Moreover, adoptive transfer of T cells from wild-
type into IL-4/ mice reversed cognitive impairment and attenuated the proinflammatory 
character of meningeal myeloid cells. Our results point to a critical role for T cell–derived 
IL-4 in the regulation of cognitive function through meningeal myeloid cell phenotype and 
brain-derived neurotrophic factor expression. These findings might lead to the development 
of new immune-based therapies for cognitive impairment associated with immune decline.
© 2010 Derecki et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial– 
Share  Alike  3.0  Unported  license,  as  described  at  http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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(Kipnis et al., 2004; Brynskikh et al., 2008). We were inter-
ested to see if immunosuppressive drugs, currently in clinical 
trials or used in disease treatment, would yield a similar pheno-
type of cognitive impairment. To that end, wild-type mice 
were treated daily by oral administration of 1 mg/kg FTY720, 
a compound that causes internalization of the sphingosine 
1-phosphate receptor 1 on thymocytes and lymphocytes, thus 
sequestering these cells in lymph nodes and inducing periph-
eral lymphopenia (Brinkmann et al., 2002; Yang et al., 2003; 
Kharel et al., 2005).
To examine whether acute T cell depletion would impair 
learning and memory, we treated animals daily with an oral 
administration of 1 mg/kg FTY720 starting 1 wk before the 
initiation of training in the MWM spatial learning and memory 
task. Animals were continued on FTY720 treatment through-
out training. FTY720-treated mice took significantly lon-
ger to find the hidden platform during the acquisition phase 
(the average of all four trials per day is presented; Fig. 1 a, i). 
When the platform was removed for the probe trial (removal 
of the platform is intended to test the strength of the acquired 
memory, and thus the percentage of time spent by mice in the 
quadrant where the platform was originally located is calcu-
lated), FTY720-treated mice spent significantly less time in 
the training quadrant than control mice (Fig. 1 a, ii). To fur-
ther characterize memory deficits of FTY720-treated mice, 
we also examined the number of crossings the mice made 
through a circular area circumscribing the original platform 
location and the time required for the first crossing of this 
area. FTY720-treated mice fared significantly worse on both 
of these parameters (Fig. 1 a, iii and iv) than controls. On the 
reverse trial, when the platform was placed in the quadrant 
opposite to the original, PBS-treated mice exhibited normal 
learning within the 2 d, whereas the learning of FTY720-
treated mice was significantly attenuated (the average of each 
individual trial is presented to follow the improvement in the 
performance; Fig. 1 a, v). No difference between the groups 
was evident in the visible platform task performed on day 8 
(not depicted), suggesting no difference in motor function, 
vision, or motivation to escape the water.
At the end of MWM training, peripheral immunity was 
examined. As expected, lymphocyte levels in circulating blood 
were significantly reduced in FTY720-treated as compared 
with PBS-treated mice (Fig. S1).
To support the notion that FTY720’s effect was through 
suppression of the immune response, we treated severe 
combined immune-deficient (SCID) mice with FTY720 in a 
regimen identical to that used for wild-type mice (1 mg/kg 
starting 1 wk before the initiation of training in the MWM). 
SCID mice performed poorly on the MWM, as was ex-
pected from previous studies (Kipnis et al., 2004; Brynskikh 
et al., 2008), and treatment with FTY720 did not affect their 
performance (Fig. 1 b).
To eliminate T cells from meningeal spaces instead of cre-
ating peripheral lymphopenia, we used anti-VLA4 antibodies   
that have previously been shown to be effective in their inhi-
bition of T cell migration into the CNS (Yednock et al., 1992).   
counterparts,  their  performance  on  learning  and  memory 
tasks significantly improved (Kipnis et al., 2004). Injection of 
T cell–deficient mice with T cell–depleted splenocytes did 
not affect their performance, indicating that cognitive improve-
ment was T cell dependent (Brynskikh et al., 2008). A recent 
study showed that acute depletion of T cells by administration 
of anti-CD3 antibodies results in cognitive impairment within 
5 d, and that the effect is mediated by CD4+ but not CD8+ 
T cells (Wolf et al., 2009).
Although the function of the healthy brain is affected by 
the immune system (Kipnis et al., 2004; Ziv et al., 2006), under 
normal physiological conditions no T cells are found in the 
CNS parenchyma. However, the brain and spinal cord are 
surrounded by a multipartite membranous covering—the 
meninges—comprising an outer dura mater, intermediate 
arachnoid mater, and inner pia mater. Cerebrospinal fluid 
(CSF), produced by choroid plexus epithelia, flows within the 
confines of the meninges (Cserr and Knopf, 1992; Ransohoff 
et al., 2003). CSF drains into cervical lymph nodes (Widner 
et al., 1988), enabling peripheral T cells to respond to CNS 
antigens under certain pathological conditions. Thus, although 
immune cell access to the CNS parenchyma of the healthy 
brain is restricted, access to the meninges and choroid plexus 
is more feasible. Accordingly, the meninges and choroid plexus 
are heavily populated by myeloid cells, as well as by substan-
tial numbers of T cells (Qing et al., 2000; Kivisäkk et al., 2003; 
Rosicarelli et al., 2005). It is therefore plausible that neuroim-
mune interactions affecting learning and memory originate in 
the meninges and choroid plexus/ventricular areas rather than 
in the parenchyma. With this in mind, we decided to examine 
the possibility that T cell function in the meningeal spaces is a 
prerequisite for the role of these cells in learning and memory.
In this paper we show that in wild-type mice trained in a 
spatial learning and memory task, the Morris water maze 
(MWM), IL-4–producing T cells accumulate in meningeal 
spaces. Acute depletion of T cells from meningeal spaces results 
in impairment of learning and memory, and the appearance of a 
skewed proinflammatory phenotype of meningeal myeloid cells. 
Strikingly, IL-4/ mice exhibited a skewed proinflammatory 
meningeal myeloid phenotype and cognitive impairment remi-
niscent of that seen in T cell–depleted mice, and was reversed by 
injection of wild-type T cells. Moreover, transplantation of 
bone marrow from IL-4/ mice into irradiated wild-type mice 
resulted in cognitive impairment and proinflammatory menin-
geal myeloid skew reminiscent of that seen in IL-4/ mice, 
linking meningeal T cell–derived IL-4 to meningeal myeloid 
cell phenotype and cognitive function. The regulation of brain-
derived neurotrophic factor (BDNF) as a possible mechanism 
underlying the beneficial role of T cell–derived IL-4 is shown.
RESULTS
Acute suppression of T cells results in impairment  
of learning and memory
Several genetically immunodeficient mouse strains have pre-
viously been shown to exhibit severe cognitive impairment 
when examined on tests of spatial learning and memory JEM VOL. 207, May 10, 2010 
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Animals were given three i.p. injections of 1.2 mg anti-VLA4 
per mouse (or the same amount of rat IgG for control mice)   
5 d before the beginning of MWM, 1 d before the training, and 
after 4 d of training. Anti-VLA4–treated mice took signifi-
cantly longer to find the hidden platform during the acquisi-
tion phase (Fig. 1 c, i). When the platform was removed for 
the probe trial, anti-VLA4–treated mice spent significantly less   
time in the training quadrant than control mice (Fig. 1 c, ii). 
The number of crossings of the original platform location 
made by control mice were significantly higher than those 
made by anti-VLA4–treated mice (Fig. 1 c, iii). Finally, the 
latency for anti-VLA4–treated mice to first cross the original 
location of the platform was significantly greater than that of 
control mice (Fig. 1 c, iv). On the reverse trial, control mice 
exhibited normal learning within the 2 d, whereas the learn-
ing of anti-VLA4–treated mice was significantly attenuated 
(Fig. 1 c, v). No difference between the groups was evident 
in the visible trial (not depicted).
To address the possible differential effect of long- vs. 
short-term treatment with these drugs, we treated animals 
with either 4.3 × 103 mg/ml FTY720 in drinking water or 
injected them with 1.2 mg anti-VLA4 per mouse two times 
a week over a period of 8 wk. Two control mouse groups 
were used: rat IgG treated (at the same volume/frequency) 
and untreated. Both groups of control mice were identical 
and were combined for the ease of presentation. Both groups 
of treated mice exhibited substantial cognitive impairment, as 
examined in the MWM task (Fig. 1 d). Treated groups took 
significantly longer to find the hidden platform during the 
acquisition phase (Fig. 1 d, i). In a probe trial, control mice 
spent significantly more time in the training quadrant as com-
pared with the anti-VLA4–treated group (Fig. 1 d, ii). The 
number of crossings of the original platform location made by 
control mice were significantly higher than those made by 
FTY720-treated mice (Fig. 1 d, iii). Finally, the latency   
for the treated mice to first cross the original location of the 
platform was significantly greater in both treated groups than 
that of control (Fig. 1 d, iv). On the reverse trial, control 
mice exhibited normal learning within the 2 d, whereas   
the learning of anti-VLA4– and FTY720- treated mice was 
significantly  attenuated  (Fig.  1  d,  v).  No  difference  be-
tween the groups was evident in the visible platform trial 
(not depicted).
To examine the effects of immune suppression on perfor-
mance in a brief learning and memory task with minimal 
time given to training, in which an immunological response 
could not be generated, we compared control and FTY720-
treated mice (1 mg/kg for 8 d before the examination) in 
contextual fear conditioning, an assay requiring only brief 
training (one 10-min training session). FTY720-treated mice 
did not show any difference in freezing behavior within the 
training context as compared with their control counterparts 
(Fig. 1 e), suggesting that in a temporally truncated learning 
and memory task, wherein a salient immune response cannot 
be built within the time frame, a lack of T lymphocytes does 
not affect learning behavior.
Meningeal T cell response after MWM learning  
and memory task performance
In an attempt to better understand the cellular and molecular 
mechanisms underlying the observed beneficial effect of   
T cells on performance in the MWM, we examined T cell   
response after task performance. Immunohistological exami-
nation of brain tissue did not reveal any T cells in brain paren-
chyma from either naive or MWM-trained mice. However,   
T cells were prominently evident in meningeal areas: sub-
arachnoid spaces (Fig. 2 a), ventricle walls, and choroid plexus 
(not depicted). Meningeal contents of T cells were quantified 
by stereological counting of CD3+ cells in coronal slices. 
A significant increase in CD3+ cells was evident in the menin-
ges of mice that underwent training in the MWM task (Fig. 2 b). 
To substantiate these results, single-cell suspensions of menin-
geal tissue from control and MWM-trained mice were pre-
pared and examined by FACS. The series of gates that allow 
reliable identification of the population of meningeal T cells is 
illustrated in Fig. 2 c (see Materials and methods). A substantial 
increase in CD3+CD4+ cell numbers was evident in meninges 
of MWM-trained as compared with control mice (Fig. 2 c, iv). 
From FACS data we extrapolated the total numbers of CD4+ 
and CD8+ T cells in the meninges of naive and trained wild-
type mice. A significant increase in CD4+ but not CD8+ T cell 
numbers after training is evident (Fig. 2 d). Numbers obtained 
using this calculation method were similar to those obtained 
by stereological counting (Fig. 2 a) but slightly higher, likely 
because of the fact that the entirety of the meninges, includ-
ing meningeal tissue surrounding the cerebellum and olfac-
tory bulbs of the brain, is used in FACS.
To further characterize T cells from naive and MWM-
trained wild-type mice, we examined their activation pheno-
type. A substantial increase in CD69-expressing meningeal 
CD4+ T cells was evident after training, whereas meningeal 
CD8+ T cells did not show induction of the early activation 
marker CD69 (Fig. 2 e). Because only CD4+ T cells had been 
activated in response to task performance and this is the 
major T cell population in the meninges (Fig. 2 d), we con-
centrated on this population. We also examined expression of 
the CD25 activation marker on CD4+ T cells. To exclude 
the population of naturally occurring regulatory T cells con-
stitutively expressing CD25, the negative fraction of Foxp3-
labeled  cells  was  examined  for  CD25  expression.  Indeed, 
meningeal  cells  from  MWM-trained  mice  showed  an  in-
crease in CD4+Foxp3–CD25+ cells (Fig. 2 f). Next, T cells 
were examined for intracellular cytokine profile. A striking 
induction in IL-4–producing CD4+ T cells was revealed in the 
meninges of MWM-trained mice, whereas IFN-–producing 
T cells were not substantially changed after MWM train-
ing (Fig. 2 g).
We examined meningeal immunity after treatment with 
FTY720 or anti-VLA4. With FTY720 treatment, CD4+  
T cells in the meninges were dramatically reduced in numbers 
(Fig. 2 h). The presented populations were gated for CD45+ 
and CD3+ and then examined for CD4 expression. Although 
a massive general reduction in all T cells was evident (Fig. 2 h), 1070 Meningeal immunity in learning and memory | Derecki et al.
Figure 1.  Depletion of T cells is correlated with impairment of learning and memory in the MWM task. All behavior experiments were  
performed by an experimenter blinded to the identity of the experimental groups and were recorded with the EthoVision video tracking system. Repre-
sentative experiments are shown out of at least two to three independently performed in each case. (a, i–v) PBS- (control) and FTY720-treated mice of an 
identical genetic background (BALB/c) were monitored during the MWM task. During the acquisition (i) and reversal (v) phases of the task, FTY720-treated 
mice took significantly longer than controls to locate the hidden platform. Two-way repeated measures ANOVA was used for statistical analysis  
(*, P < 0.05 for overall acquisition; **, P < 0.01 for reversal day 2). The Bonferroni post-hoc test was used for individual pair comparisons (n = 8–9 mice/
group; *, P < 0.05; **, P < 0.01). A probe trial was performed on day 5, and the percentage of time spent in the training quadrant (ii), the number of times 
each mouse passed over a circular space circumscribing the location of the original platform (iii), and the latency to reach the original platform location 
(iv) were recorded. FTY720-treated mice showed significantly reduced time spent in the training quadrant (ii), passed over the original platform location 
fewer times (iii), and took significantly longer to successfully locate the original platform location (iv; Student’s t test; *, P < 0.05; ***, P < 0.001).  
(b, i–v) Control and FTY720-treated SCID mice of an identical genetic background (BALB/c) were monitored during the MWM task. No differences were 
seen in either the acquisition (i) or reversal phase (v). A probe trial was performed on day 5, and the percentage of time spent in the training quadrant (ii), 
the number of times each mouse passed over a circular space circumscribing the location of the original platform (iii), and the latency to reach the original 
platform location (iv) were recorded. FTY720-treated SCID mice did not differ from control SCID mice in time spent in any of the these measures  
(*, P < 0.05; n = 8–9 mice/group). (c, i–v) Control and anti-VLA4–treated mice of an identical genetic background (BALB/c) were monitored during the 
MWM task. During the acquisition (i) and reversal (v) phases of the task, anti-VLA4–treated mice took significantly longer than controls to locate the  JEM VOL. 207, May 10, 2010 
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the MWM. CD4+ T cells were found in meningeal isolates 
of T cell–injected mice (Fig. 3 f), and meningeal myeloid 
cells obtained from mice injected with wild-type T cells exhib-
ited lower numbers of TNF-producing CD11b+ cells than 
PBS-injected counterparts (Fig. 3 g). IL-4/ T cells were 
also found in the meningeal spaces of SCID recipients (Fig. 3 f); 
however, they did not affect the proinflammatory skew of 
meningeal myeloid cells (Fig. 3 g).
Analysis of the aforementioned meningeal myeloid cells 
was based on a series of gates applied to all samples, as indi-
cated in Fig. 3 h, using a viability dye (live/dead gate for the 
elimination of dead cells; i), side/forward scatter (scatter gate 
for the elimination of cell debris; ii), CD45 versus event 
count (leukocyte gate for the identical number of analyzed 
leukocytes; iii), pulse width (singlets gate for the elimination 
of cell aggregates; iv), and CD11b, a myeloid cell marker 
(a myeloid gate; 3 × 103 myeloid cells were analyzed from 
each sample as indicated; v).
The essential role of IL-4 in the regulation of meningeal 
myeloid cells and in cognitive task performance
To further address the role of T cell–derived IL-4 in the reg-
ulation of meningeal myeloid cell phenotype and, in turn, of 
cognitive function, we examined IL-4/ mice in terms of 
their MWM task performance. IL-4/ mice exhibited an 
astonishingly severe phenotype of impaired cognitive function 
when compared with their wild-type controls. IL-4/ mice 
took significantly longer to find the hidden platform during 
the acquisition phase (Fig. 4 a, i). In the probe trial, IL-4/ 
mice spent significantly less time in the training quadrant 
than control mice (Fig. 4 a, ii). To further characterize mem-
ory deficits of IL-4/ mice, we also examined the number 
of crossings of the original location of the platform and the 
time required for the first crossing that the mice made to the 
original platform location. IL-4/ mice fared significantly 
worse on both parameters measured than did their wild-type 
counterparts (Fig. 4 a, iii and iv). On the reverse trial, IL-4/ 
mice also exhibited a remarkable impairment (Fig. S2). No 
difference between the groups was evident in the visible plat-
form trials (not depicted).
To link the cognitive impairment seen in IL-4/ mice 
with meningeal immunity, we examined meningeal myeloid 
when the CD4+ T cells from control and FTY720-treated 
meninges were examined for memory/naive cell markers,   
naive CD62L+ and/or CD44lo cells were clearly the most   
affected by FTY720 treatment (Fig. 2 i). Treatment with an 
antibody to VLA4 eliminated a majority of CD4+ T cells from 
the meninges (Fig. 2 j), with memory cells, expressing high 
levels of CD44, affected more than others (Fig. 2 k).
Meningeal myeloid cell response after cognitive task 
performance and its T cell–dependent regulation
In addition to T cells, the meninges are also well populated 
by myeloid cells. Micrographs of choroid plexus demonstrate   
CD68+ cells (myeloid origin) expressing MHCII (Fig. 3 a). 
These cells are representative of those observed in subarachnoid 
spaces and in ventricular walls (not depicted), i.e., through-
out the meninges. Given the observed changes in meningeal 
T cells upon MWM training we reasoned that concomitant 
changes might be apparent in the meningeal myeloid popula-
tion. Indeed, a substantial induction in activated myeloid cells 
(CD69+) was evident in the meninges of mice after MWM 
task performance (Fig. 3 b).
To address the possibility that T cells might be involved 
in the regulation of the phenotype of meningeal myeloid 
cells, we examined their expression of proinflammatory cyto-
kines upon acute depletion of meningeal T cells using either 
FTY720 or anti-VLA4 antibody treatment. CD11b+ cells 
isolated from the meninges of FTY720- or anti-VLA4– 
treated mice exhibit higher levels of the proinflammatory 
cytokines TNF and/or IL-12 (Fig. 3, c and d), suggesting that 
in the absence of T cells, meningeal myeloid cells acquire a 
skewed proinflammatory phenotype in response to cognitive 
task performance.
To further support this hypothesis, we examined the cyto-
kine profile of meningeal myeloid cells from wild-type and 
SCID mice (lacking both T and B lymphocytes) after MWM 
training. Meningeal myeloid cells from SCID mice expressed 
significantly higher levels of TNF and IL-12 than those from 
wild-type mice (Fig. 3 e). Moreover, we compared menin-
geal immunity in control SCID mice and SCID mice repop-
ulated with T cells. SCID mice were injected i.p. with 20 × 106 
CD3+ T cells isolated from syngeneic wild-type or IL-4/ 
mice or with PBS (control), and after 2 wk were trained in 
hidden platform. Two-way repeated measures ANOVA was used for statistical analysis (*, P < 0.05; and **, P < 0.01 for both acquisition and reversal).  
The Bonferroni post-hoc test was used for individual pair comparisons (n = 8 mice/group; *, P < 0.05; **, P < 0.01). During the probe trial, anti-VLA4–
treated mice showed significantly reduced time spent in the training quadrant (ii), passed over the original platform location fewer times (iii), and took 
significantly longer to successfully locate the original platform location (iv; Student’s t test; *, P < 0.05; **, P < 0.01). (d, i–v) Control and long-term 
FTY720- and anti-VLA4–treated mice of an identical genetic background (BALB/c) were monitored during the MWM task. During the acquisition (i) and 
reversal (v) phases of the task, both FTY720- and anti-VLA4–treated mice took significantly longer than controls to locate the hidden platform. Two-way 
repeated measures ANOVA was used for statistical analysis (*, P < 0.05; and **, P < 0.01 for both acquisition and reversal). The Bonferroni post-hoc test 
was used for individual pair comparisons (n = 6–7 mice/group; *, P < 0.05). During the probe trial, anti-VLA4–treated mice showed significantly reduced 
time spent in the training quadrant (iii) and took significantly longer to successfully locate the original platform location (iv). FTY70-treated mice passed 
over the original platform location fewer times (ii) and took significantly longer to successfully locate the original platform location (iv; Student’s t test;  
*, P < 0.05; ***, P < 0.001). (e) Mice were placed in a conditioning context for 2 min before receiving five tone/shock pairings spaced by 1-min inter-trial 
intervals. 48 h later the mice received a 5-min test in the training context. Freezing was scored via an automated system during all sessions and used as 
an index of memory. No differences were seen between control and FTY720-treated mice. Error bars represent SEM.
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bone marrow transplantation from IL-4/ mice to irradiated 
wild-type recipients was performed. 40 d after bone marrow 
transplantation, mice were examined for their performance 
in the MWM. A significant but partial (compared with   
IL-4/ mice) impairment in MWM task performance was 
evident in IL-4/ bone marrow recipients as compared with 
control counterparts that received bone marrow from wild-
type mice. Mice that received bone marrow from IL-4/ 
donors took significantly longer to find a hidden platform 
than controls (Fig. 4 d, i). In the probe trial, IL-4/ bone 
marrow recipient mice spent less time in the training quad-
rant than control mice, albeit no statistical significance was 
observed in this particular measurement (Fig. 4 d, ii). To fur-
ther characterize memory deficits of IL-4/ bone marrow 
recipient mice, we examined the number of crossings of the 
original location of the platform and the time required for the 
cells for cytokine expression. A significant increase in pro-
inflammatory cytokine production (TNF) by meningeal 
myeloid cells from IL-4/ mice was evident as compared 
with myeloid cells from the meninges of wild-type counter-
parts (Fig. 4 b). To substantiate that the results shown in me-
ninges by FACS were relevant to areas in the CNS involved 
in spatial learning and memory, we also looked at levels of 
mRNA for TNF in hippocampi from MWM-trained wild-
type  and  IL-4/  mice  by  quantitative  real-time  PCR 
(qRT-PCR).  Hippocampi  from  MWM-trained  IL-4/ 
mice  showed  significantly  higher  levels  of  TNF  mRNA 
(Fig. 4 c). No neurodevelopmental abnormalities were found 
in IL-4/ mouse brain gross anatomy compared with wild-
type counterparts (Fig. S3).
To link the observed results to the effects of immune- 
derived IL-4, we undertook the following experiments. First, 
Figure 2.  Accumulation and activation of IL-4–producing T cells in the meningeal spaces of MWM-trained mice. (a and b) Whole brain cryo-
sections were labeled for CD3. Subarachnoid spaces occupied by CD3+ cells are presented, and arrowheads point to CD3+ cells. Bar, 50 µm (a). CD3+ cells 
were stereologically counted. A significant increase in CD3+ cells was found in trained mice (b). (c, i–iii) Meningeal single-cell suspensions were examined 
by FACS for CD3+/CD4+ cells in naive and MWM-trained mice. In each sample, 104 CD45hi events were examined (i); CD45hi events were gated by scatter 
(ii), and CD4 versus CD3, revealing an increase in CD4+ T cells in the meninges of trained mice (iii). Experiments were performed three separate times with 
meninges pooled from four mice with similar results. The FACS plot shown is representative (c, iv). (d) The entirety of one single sample from each group 
(naive or MWM-trained) was read by FACS and normalized to one another by CD45hi count and gated on CD3, CD4, and CD8. The numbers of CD3+/CD4+ 
and CD3+/CD8+ cells obtained from each sample were multiplied by the total number of samples prepared from the group and divided by four (the num-
ber of mice in the group) to arrive at a representative CD4+ and CD8+ T cell count per single mouse meninges. Meningeal preparations from MWM-
trained mice displayed significantly higher numbers of CD4+ but not CD8+ T cells than meningeal preparations from naive mice. Error bars represent SEM. 
(e and f) CD3+ cells from meninges of naive and MWM-trained mice were examined for expression of the activation markers CD69 and CD25, and the 
cytokines IL-4 and IFN-. CD4+ but not CD8+ cells from MWM-trained mice showed approximately threefold up-regulation in expression of CD69 (e) and 
similar up-regulation in effector (Foxp3) T cells expressing CD25 (f) as compared with cells from naive mice. Cells from MWM-trained mice also showed 
a substantial increase in intracellular expression of IL-4 but not IFN- as compared with naive animals (g). (h–k) FACS analysis of meningeal isolates from 
MWM-trained FTY720-treated and control mice (h and i), and anti-VLA4–treated and control mice (j and k). Analysis of CD3+ cells from meninges of 
FTY720-treated mice indicates a reduction in meningeal CD4+ T cells as compared with controls; numbers indicate cell counts and reflect the analyzed 
sample rather than the content of the entire meningeal isolation (h); a specific reduction in CD44loCD62L+ (TNaive) subpopulation in FTY720-treated mice is 
presented (i). Anti-VLA4–treated mice exhibit reduction in meningeal CD4+ T cells as compared with controls (j), particularly the subpopulation character-
ized by the CD44hi/CD62L (TEffector Memory) phenotype (k). At least two independent experiments with at least four mice in each group were performed. 
Results from independent experiments are shown. Numbers indicate percentages.JEM VOL. 207, May 10, 2010 
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with wild-type T cells spent significantly more time in the 
training quadrant than mice injected with IL-4/ T cells 
(Fig. 4 f, ii). Moreover, on the additional two memory 
parameters—the number of crossings of the original location 
of the platform and the time required for the first crossing 
that the mice made to the original platform location—mice 
injected with T cells from wild-type mice exhibited sig-
nificantly better function than mice injected with IL-4/  
T cells (Fig. 4 f, iii and iv). Examination of meningeal my-
eloid cells from these two groups of mice revealed that mice 
injected with wild-type T cells demonstrated a striking ame-
lioration of the proinflammatory meningeal myeloid skew 
characteristic to IL-4/ mice (Fig. 4 g). In contrast, injec-
tion of IL-4/ recipients with IL-4/ T cells did not affect 
meningeal myeloid cell phenotype (Fig. 4 g). Meningeal iso-
lates from IL-4/ mice that received GFP+ T cells were also 
labeled extracellularly for CD3 and CD4, and intracellularly 
for IFN- and IL-4. GFP+ (wild-type, transferred) and GFP 
(endogenous) CD4+ T cells were compared for expression of 
first crossing that the mice made to the original platform   
location. IL-4/ bone marrow recipients fared significantly 
worse on both parameters measured than did controls (Fig. 4 d, 
iii and iv). Examination of meningeal myeloid cells from 
these two groups of mice revealed a marked proinflammatory 
skew in meningeal myeloid cells of mice that received bone 
marrow from IL-4/ mice as compared with wild-type bone 
marrow recipients (Fig. 4 e).
In an additional experiment, IL-4/ mice were injected 
i.p. with 20 × 106 T cells from either wild-type mice express-
ing GFP under the ubiquitin C (UBC) promoter (i.e., in-
jected T cells are GFP+) or IL-4/ donors and were tested 
2 wk later in the MWM. Although IL-4/ T cells did not 
affect the MWM performance of IL-4/ mice, injection of 
these mice with T cells from wild-type donors significantly 
improved their performance in the MWM task (Fig. 4 f). 
Wild-type T cell–injected IL-4/ mice took significantly 
less time to find a hidden platform than IL-4/ T cell– 
injected controls (Fig. 4 f, i). In the probe trial, mice injected 
Figure 3.  T cell–dependent regulation of 
meningeal myeloid cell phenotype in 
MWM-trained mice. (a) Whole brain cryo-
sections were double labeled for CD68 and 
MHCII. Positive cells (myeloid) in the choroid 
plexus of the third ventricle are presented. 
Bars, 50 µm. (b–e) FACS analyses were per-
formed at least three times independently 
with at least three to four mice in each group. 
Numbers on histograms indicate actual cell 
counts. CD11b+ cells from meninges of MWM-
trained animals display a marked increase in 
the expression of CD69 as compared with 
naive animals (b). CD11b+ cells from the  
meninges of acutely immunosuppressed 
FTY720-treated animals show a proinflamma-
tory skew as measured by TNF and IL-12  
expression (c). Anti-VLA4–treated animals 
display an increase in the expression of the 
proinflammatory cytokine IL-12 in meningeal 
myeloid cells (d). CD11b+ cells from the  
meninges of chronically immunodeficient 
SCID mice display a proinflammatory skew in 
comparison to controls, as measured by TNF 
and IL-12 expression (e). (f and g) SCID mice 
injected i.p. with PBS, 2 X 106 T lymphocytes 
from IL-4/ mice, or 2 X 106 T lymphocytes 
from wild-type mice. At least six mice in each 
group were analyzed in two independent 
experiments. Plots depict CD3+/CD4+cells 
isolated from the meninges of transfused 
SCID mice (numbers indicate percentages; f). 
Histograms show TNF expression as measured 
by FACS analysis of meningeal cells expressing 
CD11b. CD11b+ cells from the meninges of SCID mice transfused with wild-type T cells showed a reduction in proinflammatory cytokine production, and 
SCID mice transfused with T cells from IL-4/ mice showed no such reduction (g). (h) Representative labeling and gating scheme for meningeal myeloid 
cells in b–e and g by FACS is presented. Viable cells as determined by a live/dead gate (i), forward and side scatter to eliminate debris (ii), CD45hi cells to 
eliminate possible microglial contamination (iii), and single-cell selection as determined by pulse width versus area gate (iv), CD11b+ gate. CD45/event 
count gates were adjusted to yield identical numbers (3 X 103) of myeloid-derived cells in each sample.1074 Meningeal immunity in learning and memory | Derecki et al.
Figure 4.  T cell–derived IL-4 regulates meningeal myeloid cell phenotype and influences learning and memory. All behavior experiments 
were performed by an experimenter blinded to the identity of experimental groups and were recorded with the EthoVision video tracking system.  
Representative experiments are shown out of at least two to three independently performed in each case. (a, i–iv) Control and IL-4/ mice of identical 
genetic background (C57BL/6J) were monitored during the MWM task performance. During the acquisition (i) phase of the task, IL-4/ mice took  
significantly longer than controls to locate the hidden platform. Two-way repeated measures ANOVA was used for statistical analysis (***, P < 0.001). 
During the probe trial, IL-4/ mice showed significantly reduced time spent in the training quadrant (ii), passed over the original platform location 
fewer times (iii), and took significantly longer to successfully locate the original platform location (iv; Student’s t test; *, P < 0.05; **, P < 0.01;  
***, P < 0.001). (b, e, and g) Meningeal isolates from mice were labeled for viability, CD45, singlet cells, and CD11b to allow exact comparison of cells  
(see Fig. 3 h for detailed gating strategy). Cells were also labeled for IL-12 and/or TNF expression. Histograms represent comparative proinflammatory 
cytokine production of 3 × 103 viable, CD45hi, CD11b+ singlet cells from each group. Numbers on the histograms indicate actual cell counts. Meningeal 
isolates from MWM-trained wild-type and IL-4/ mice demonstrate increased production of TNF by CD11b+ cells in IL-4/ mice (b). FACS data shown 
are from one out of two independent experiments with similar results and are representative. (c) Hippocampal tissue from wild-type and IL-4/ mice 
was compared by qRT-PCR for relative levels of TNF mRNA expression; hippocampal isolates from IL-4/ mice displayed significantly higher levels of 
TNF mRNA. One-way ANOVA was used for statistical analysis (*, P < 0.05; n = 4 from each group; experiment was repeated two times). (d, i–iv) Lethally 
irradiated wild-type mice reconstituted with bone marrow from wild-type or IL-4/ mice were monitored during the MWM task performance. During 
the acquisition (i) phase of the task, mice that had received IL-4/ bone marrow took significantly longer than controls to locate the hidden platform. 
Two-way repeated measures ANOVA was used for statistical analysis (n = 7 in each group; *, P < 0.05; **, P < 0.01). During the probe trial, mice that 
had received IL-4/ bone marrow passed over the original platform location significantly fewer times (iii) and took significantly longer to successfully 
locate the original platform location (iv; Student’s t test; *, P < 0.05; **, P < 0.01). (e) Meningeal isolates were prepared from each group (n = 4 pooled 
samples), labeled as described, and analyzed by FACS. CD11b+ cells from mice that received bone marrow from IL-4/ mice demonstrated increased 
levels of IL-12 and TNF. (f, i–iv) IL-4/ mice received i.p. injection of 2 × 106 T cells from wild-type mice (expressing GFP under the UBC promoter) or 
IL-4/ mice, and were tested after 2 wk in the MWM. During the acquisition (i) phase of the task, mice that had received IL-4/ T cells took significantly JEM VOL. 207, May 10, 2010 
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DISCUSSION
In this study we describe cellular and molecular mechanisms 
underlying  T  cell–mediated  beneficial  effects  on  cognitive 
function. We show that T cell deficiency skews meningeal 
myeloid immunity toward a proinflammatory phenotype. We 
further show that in wild-type mice, the performance of cog-
nitive tasks leads to the accumulation of IL-4–producing (Th2) 
cells in the meninges. Along these lines, deficiency of T cell–
derived IL-4 results in severe cognitive impairment and in a 
proinflammatory skewing of meningeal myeloid cell pheno-
type. Meningeal T cell–derived IL-4 was shown in this study 
to play a dual role in the maintenance of cognitive function: it 
antagonizes the deleterious effects of proinflammatory cyto-
kines on astrocytes and neurons, and promotes the expression 
of an astroglial phenotype supportive of cognitive function 
(such as increased production of BDNF by astrocytes).
Although T cells have been shown to exert beneficial effects 
on cognitive function (Brynskikh et al., 2008), no plausible 
molecular mechanism has yet been offered to account for 
these effects. One suggestion was that T cells invade the neural 
parenchyma and interact directly with neurons or, alterna-
tively, with glial cells (microglia and astrocytes), thus af-
fecting neuronal function indirectly (Kipnis et al., 2004; Ziv 
et al., 2006). A major problem with this parenchymal con-
tact–based hypothesis, however, was the conspicuous absence 
of T cells in the CNS parenchyma. We show in this paper 
that a substantial T cell response to cognitive training does 
indeed take place, but that it occurs in the choroid plexus, 
ventricular margins, and subarachnoid spaces rather than in 
the parenchyma. Common to these three areas is their close 
spatial proximity to the brain parenchyma, as well as their 
ability to interact with both the peripheral circulation and 
the CSF (Ransohoff et al., 2003; Ransohoff and Trapp, 2005; 
Rebenko-Moll et al., 2006).
After wild-type mice were trained in the MWM, their 
meningeal T cells (primarily the CD4+ population) exhibited 
heightened activation. These findings are in line with a previ-
ous suggestion that CD4+ rather than CD8+ T cells participate 
in the regulation of neural plasticity and cognitive function 
intracellular cytokines. GFP+ T cells expressed high levels of 
IL-4 and low levels of IFN-, whereas GFP T cells ex-
pressed no IL-4 and high levels of IFN- (Fig. 4 h).
To gain insight into the possible downstream neural 
mechanism mediated by the meningeal cytokine milieu, we 
examined the effect of different cytokines and their combina-
tions on astrocytic expression of BDNF. BDNF has been 
shown to be a key molecule in several learning and memory 
paradigms, including the MWM (Hall et al., 2000; Choy et al., 
2008). It is also expressed by astrocytes and could potentially 
be regulated by cytokines because of the expression on astro-
cytes of most of the major cytokine receptors (Benveniste, 
1992; Ridet et al., 1997). Primary astrocytes after 21 d in 
culture were treated with IL-4, TNF, IL-12, or a combina-
tion of TNF or IL-12 with IL-4, and levels of BDNF mRNA 
were examined using qRT-PCR. Astrocyte cultures treated 
with proinflammatory cytokines demonstrated reduced levels 
of BDNF mRNA, in line with previous findings (Aharoni et al., 
2005).  We  additionally  demonstrate  that  IL-4  increases 
BNDF mRNA levels in astrocytes (Fig. 4 i) and, surprisingly, 
can significantly abrogate the BDNF mRNA reduction in-
duced  by  proinflammatory  cytokines  in  primary  astrocyte 
cultures (Fig. 4 i), suggesting that T cell–derived IL-4 could 
be affecting levels of parenchymal BDNF expression. Astro-
cytes are in close contact with “brain borders,” i.e., menin-
geal areas, and thus could be regulated by meningeal cytokines. 
Confocal images represent glial fibrillary acidic protein–positive 
(astrocytic marker) cells expressing BDNF in close prox-
imity to the ventricular walls and the hippocampus (Fig. 4 j). 
To quantify the differences in overall BDNF expression 
levels, we compared levels of BDNF mRNA from wild-
type and IL-4/ mice before and after MWM training. 
Although wild-type mice exhibit a significant increase in levels 
of BDNF mRNA after cognitive task performance (as might 
be expected from previously published works; Kesslak et al., 
1998; Hall et al., 2000), IL-4/ mice showed no increase 
(Fig. 4 k), suggesting that IL-4 could be critical in the main-
tenance of BDNF production after performance in a learn-
ing and memory task.
longer than wild-type T cell–injected mice to locate the hidden platform. Two-way repeated measures ANOVA was used for statistical analysis (n = 8  
in each group; *, P < 0.05; **, P < 0.01). During the probe trial, mice that had received IL-4/ T cells showed significantly reduced time spent in the 
training quadrant (ii), passed over the original platform location significantly fewer times (iii), and took significantly longer to successfully locate the 
original platform location as compared with mice receiving T cells from wild-type donors (iv; Student’s t test; *, P < 0.05). (g) Meningeal isolates were 
prepared from each group (n = 4 pooled samples), labeled as described, and analyzed by FACS. CD11b+ cells from mice that received IL-4/ T cells mice 
demonstrated increased levels of IL-12 and TNF compared with wild-type T cell–injected mice. (h) Meningeal isolates from IL-4/ mice that received 
GFP+ T cells were also labeled extracellularly for CD3 and CD4, and intracellularly for IFN- and IL-4. GFP+ (wild-type, transferred) and GFP (endog-
enous) CD4+ T cells were compared for expression of intracellular cytokines. GFP+ T cells expressed high levels of IL-4 and low levels of IFN-, whereas 
GFP T cells expressed no IL-4 and high levels of IFN-. Numbers indicate percentages. (i) Primary cultures of astrocytes from wild-type mice were 
treated with 10 ng/ml of various recombinant cytokines. After 8 h, mRNA was isolated from astrocyte cultures and analyzed by qRT-PCR. Relative ex-
pression of BDNF mRNA under different treatment conditions is presented. One-way ANOVA was used for statistical analysis (*, P < 0.05). One repre-
sentative experiment out of two independently performed experiments is presented. (j) Representative confocal images of astrocytes (glial fibrillary 
acidic protein; GFAP) lining the borders of the brain expressing BDNF are presented. Arrows indicate examples for areas of colocalization. DG, dentate 
gyrus; LV, lateral ventricle; 3rdV, third ventricle. (k) Hippocampi from naive and MWM-trained wild-type and IL-4/ mice were examined for BDNF 
expression using qRT-PCR. Relative levels of BDNF mRNA expression are presented. One-way ANOVA was used for statistical analysis (**, P < 0.01; n = 4 
from each group). One representative experiment out of three independently performed experiments is presented. Error bars represent SEM.
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Our results regarding the role of IL-4 in cognitive function 
are supported by a recent publication suggesting that Th2 
cells play a beneficial role in Alzheimer’s disease without en-
tering CNS parenchyma (Cao et al., 2009), with an action 
that is B cell and antibody secretion independent. Studies   
using IL-4R floxed mice (Herbert et al., 2004) should be 
performed to determine whether the major targets of menin-
geal IL-4 are myeloid cells (for IL-4–induced regulation of 
their phenotype), astrocytes (for increased BDNF production 
and/or prevention of its decrease induced by proinflammatory 
factors) or both.
Although the effects of cytokines on learning and mem-
ory have been recognized for decades, research up to now has 
focused mainly on the effect of peripheral cytokines on brain 
function, or alternatively, on the effect potentiated by direct 
injection  of  cytokines  into  the  brain  parenchyma.  In  this 
study we show, for the first time, a physiological mechanism 
for regulation of the cytokine milieu next door to the brain 
parenchyma. Anatomical proximity between the hippocam-
pus and the lateral and third ventricles further supports the 
importance of the cytokine content of the meningeal milieu.
Until recently, the observed increase in proinflamma-
tory cytokine content in the CSF of patients suffering, for 
example, from age-related dementia, was attributed to T cell– 
mediated inflammation (Hasegawa et al., 2000; Sjögren et al., 
2004; Abraham et al., 2008; Buchhave et al., 2008; Godbout 
et al., 2008). Abnormally large numbers of proinflammatory 
T cells, such as those seen in patients with multiple sclerosis, 
are indeed expected to result in a generalized proinflamma-
tory state in the CNS and associated areas, with concomitant 
cognitive deterioration. Our data now demonstrate, how-
ever, that elimination of T cells from meningeal spaces will 
also result in a similarly skewed proinflammatory innate immune 
phenotype. These findings may be of relevance for clinical 
manifestations of cognitive disturbances related to immuno-
suppressive conditions.
In summary, the results of this study provide evidence for 
a cellular mechanism that underlies complex neuroimmune 
interactions affecting learning and memory. We describe a 
multistep and multifactorial mechanism, probably originating 
in the periphery, continuing to the CSF and the meningeal 
immune cells, and concluding with the regulation of the   
cytokine content of the meningeal milieu, which could in 
turn regulate neurotrophic factors produced by neural cells. 
These results represent a major paradigm shift in the under-
standing of the role of T cells in the maintenance of the deli-
cate pro- and antiinflammatory balance within the meningeal 
milieu. Future studies will be aimed at improving our under-
standing of the nature of the interactions between T cells and 
meningeal myeloid cells that occur either via the immuno-
logical synapse or diffusible factors. It is also important to 
consider the development of therapeutic models based on   
the direct pharmaceutical modulation of meningeal myeloid 
cells, thereby circumventing the need for T cell perturba-
tion and avoiding potential complications such as auto-
immune disease.
(Ziv et al., 2006; Wolf et al., 2009). On examining cytokine 
expression in the meningeal T cells of our MWM-trained 
mice, we found that the cytokine that showed the greatest 
increase was IL-4. This striking Th2 skewing of the T cell 
phenotype pointed to a potential alternative (M2) mode of 
activation of meningeal myeloid cells by these T cells (Kang 
et al., 2008; Martinez et al., 2008; Odegaard et al., 2008). In 
the absence of T cells, mouse meningeal myeloid cells exhib-
ited a skewed proinflammatory phenotype, characterized by 
increased production of TNF and IL-12. The proinflamma-
tory skew of meningeal myeloid cells seen in SCID mice was 
reversed after injection of wild-type T cells, whereas injec-
tion of SCID mice with IL-4/ T cells had no effect on the 
meningeal myeloid cell phenotype. Accordingly, we propose 
that the interaction of T cells with meningeal myeloid cells 
during MWM training led to modification of the inflamma-
tory phenotype of the latter.
IL-4/ mice exhibited severe cognitive impairment in 
the MWM task. Moreover, we found that the meningeal 
myeloid cells of these mice were skewed toward a proinflam-
matory phenotype. To substantiate the role of T cell–derived 
IL-4 in cognitive function and meningeal myeloid cell phe-
notype, we irradiated wild-type mice and injected them with 
wild-type or IL-4/ bone marrow. 40 d after bone marrow 
reconstitution, we examined their performance on the MWM 
task. Compared with recipients of wild-type bone marrow, 
the MWM performance of mice that had received IL-4/ 
bone marrow was significantly impaired. This impairment, 
moreover, was accompanied by a proinflammatory skewing 
of their meningeal myeloid cells. In line with these findings, 
cognitive function in IL-4/ mice was restored and proin-
flammatory meningeal myeloid skew was ameliorated by pas-
sive transfer of CD3+ T cells isolated from wild-type but not 
from IL-4/ mice. These results thus established a link   
between T cell–derived IL-4 and the phenotype of menin-
geal myeloid cells and performance in the MWM.
It has long been known that proinflammatory cytokines 
are detrimental to cognitive processes when they exceed 
their physiological concentrations (Merrill and Chen, 1991; 
Hauss-Wegrzyniak et al., 1998; Reichenberg et al., 2001; 
Monje et al., 2003; Chen et al., 2007). Numerous proinflam-
matory cytokines have been shown to interfere with long-
term potentiation, a molecular basis for learning and memory 
(Bellinger et al., 1993; Curran and O’Connor, 2001; Balschun 
et al., 2004; Maher et al., 2005). In this paper we show that 
production of BDNF, a major factor in hippocampal func-
tion, is differentially regulated in astrocytes by pro- and anti-
inflammatory cytokines. When astrocytes are incubated with 
proinflammatory cytokines, BDNF mRNA production is 
reduced; however, addition of IL-4 reverses this reduction. 
Moreover, in our in vitro studies, IL-4 directly induced 
BDNF mRNA production in astrocytes. In line with these 
findings and with previously published observations (Kesslak 
et al., 1998; Hall et al., 2000), BDNF expression is increased 
in the hippocampi of wild-type mice after cognitive training. 
No such up-regulation, however, was evident in IL-4/ mice. JEM VOL. 207, May 10, 2010 
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in the quadrant opposite the original training quadrant, and the mouse was 
retrained for four sessions each day. On day 8 mice were introduced to the 
pool with a visible platform in a third quadrant, different from the first two 
training quadrants, and were recorded for four trials. Data were recorded   
using the EthoVision automated tracking system (Noldus Information Tech-
nology). Statistical analysis was performed using analysis of variance (ANOVA) 
and the Bonferroni post-hoc test. Groups were counterbalanced, i.e., run in 
alternating order on successive training days. All MWM testing was per-
formed between 10 a.m. and 3 p.m. during the lights-on phase. All behavior 
experiments were performed by an experimenter blinded to the identity of 
experimental groups. Representative experiments are shown out of at least 
two to three independently performed in each case.
Fear conditioning
Training and testing were performed in two identical chambers (28 × 21 ×   
22 cm; Med Associates, Inc.). A video camera was positioned in front of the 
chambers to allow the subjects’ behavior to be observed and recorded. The 
floor of each chamber consisted of 18 stainless steel rods (4-mm diameter) 
spaced 1.5 cm apart (center to center). The rods were wired to a shock genera-
tor and scrambler for the delivery of footshock. The chambers were cleaned 
with a 70% ethanol solution, and pans containing a thin film of the same solu-
tion were placed underneath the grid floors. Background noise (60 dB, A 
scale) was supplied by a fan positioned adjacent to the boxes. The mice were 
placed in the conditioning context for 2 min before receiving five tone (30 s, 
2.8 kHz, 85 dB)/shock (2 s, 0.5 mA) pairings spaced by 1-min inter-trial   
intervals. 48 h later the mice received a 5-min test in the training context. 
Freezing was scored by an automated system during all sessions and used as an 
index of memory. All fear conditioning or testing was performed between   
10 a.m. and 3 p.m. during the lights-on phase. The experimenter was blind to 
the genotype or drug status of all animals during the procedure and scoring.
Bone marrow isolation
Mice were sacrificed using CO2 and saturated with 70% alcohol. Skin was 
removed from the lower part of the body. Tissue was removed from hind 
legs with scissors and dissected away from the body. Remaining tissue was 
cleaned from the tibial and femoral bones and bones were separated at the 
knee joint. Bone ends were cut off. Cells were forced out of bones with a 
stream of 0.1 M PBS, pH 7.4, containing 10% fetal calf serum using a 10-cc 
syringe with a 25-gauge needle. Cells were centrifuged and resuspended at   
a concentration of 2 × 107 cells/ml in PBS. A 200-µl cell suspension was   
injected into each animal i.v.
Irradiation and bone marrow replenishment
Adult wild-type C57BL/6J mice were subjected to a lethal split dose of  
irradiation (350 rad followed 48 h later by 950 rad). 3 h after the second   
irradiation, mice were injected with 4 × 106 bone marrow cells freshly   
isolated from identical wild-type mice or from IL-4/ mice. After irradia-
tion, mice were kept on drinking water fortified with sulfamethoxazole for 
3 wk to limit infection.
FACS of meningeal isolates
Mice were thoroughly transcardially perfused with 0.1 M PBS, pH 7.4, for 
5 min immediately after the last training trial. Heads were removed and 
skulls were quickly stripped of all flesh. Mandibles were next removed, as 
was all skull material rostral to maxillae. Surgical scissors (Fine Science 
Tools) were used to remove skull tops, cutting clockwise, beginning and 
ending inferior to the right posttympanic hook. Brains and superior skulls 
were immediately placed in ice-cold FACS buffer (0.1 M PBS, 1 mM 
EDTA, 1% BSA, pH 7.4). Meninges (dura, arachnoid, and pia mater) were 
carefully removed from the interior aspect of skulls and surfaces of brains 
with forceps (Dumont #5; Fine Science Tools). Meninges from each group 
(n = 4) were pooled. Meningeal tissue was gently pressed through 70-µm 
nylon mesh cell strainers with sterile plastic plungers (BD) to yield a single-
cell suspension. Cells were centrifuged at 1,100 RPM at 4°C for 10 min, 
the supernatant was removed, and cells were resuspended in ice-cold FACS 
MATERIALS AND METHODS
Animals
Inbred male adult (8–10-wk-old) BALB/c/BySmn, CBySmn.CB17-Prkdcscid/J, 
B6.129P2-IL4tm1Cgn/J,  C57BL/6-Tg(UBC-GFP)30Scha/J,  and  C57BL/6J 
mice were purchased from the Jackson Laboratory. All animals were housed 
in temperature- and humidity-controlled rooms, maintained on a 12-h light/
dark cycle (lights on at 7:00 a.m.), and age matched in each experiment. All 
strains were kept in identical housing conditions. The lifespan of SCID and 
IL-4/ mice is comparable to that of wild-type mice, and there are no spe-
cific dietary or housing requirements for either mutant strain. Animal proto-
cols were approved by the University of Virginia Institutional Animal Care 
and Use Committee. All procedures complied with regulations of the Institu-
tional Animal Care and Use Committee at the University of Virginia.
Drug treatments
Anti-VLA4. A rat monoclonal antibody to mouse VLA4 (clone PS/2) was 
affinity purified from hybridoma supernatants and used with the permission 
of K. Ley (La Jolla Institute of Allergy and Immunology, San Diego, CA). 
Animals were given three separate injections i.p. (1.2 mg/mouse in 250 µl of 
0.1 M PBS) of antibody (or an equivalent amount of rat IgG for control 
mice). The first dose was given 5 d before the beginning of MWM training, 
the second dose was given on the day before the beginning of the task, and 
the last injection was given after 4 d of training.
FTY720 (short term). Animals were treated daily with an oral administra-
tion (1 mg/kg in 0.1M PBS by gavage) of FTY720 (or an equivalent amount 
of PBS) starting 1 wk before the initiation of training in the MWM spatial 
learning and memory task. Animals were continued on daily oral FTY720 
treatment throughout training.
FTY20 (long term). FTY720 was dissolved in drinking water (4.3 × 
103  mg/ml);  bottles  were  changed  daily  for  8  wk  before  and  during 
MWM training.
T cell isolation and transfer
Lymph nodes (axillary, inguinal, superficial, and deep cervical) were har-
vested, mashed, and passed twice through 70-µm nylon screens. T cells were 
purified (enriched by negative selection) using autoMACS, a Pan T Cell Iso-
lation Kit, and the Possel-S program (all from Miltenyi Biotec), using the 
negative fraction. A sample was labeled with CD3 fluorescent antibodies and 
analyzed by FACS for purity. Populations analyzed contained >95% CD3+  
T cells. T cells were counted using a hemacytometer and trypan blue. Each 
mouse was injected i.p. with 2 × 107 viable T cells suspended in 250 µl of   
0.1 M PBS, pH 7.4.
MWM
Mice were given four trials per day, for 4 consecutive days, to find a hidden 
10-cm diameter platform located 1 cm below the water surface in a pool   
1 m in diameter. The water temperature was kept between 21 and 22°C. 
Water was made opaque with nontoxic tempera. Within the testing room, 
only distal visual shape and object cues were available to the mice to aid in 
location of the submerged platform. The BALB/c mice used in this study 
have poor vision and cannot fully see the shapes and objects, although they 
can distinguish light from darkness. In previous studies we have addressed 
this possible problem by using lights as visual cues, and for the visible trial we 
attached a glowing stick to the platform. Changing the objects on the walls 
to lights and adding the glowing stick significantly improves the learning 
ability of BALB/c mice in this task. The escape latency, i.e., the time re-
quired by the mouse to find and climb onto the platform, was recorded for 
up to 60 s. Each mouse was allowed to remain on the platform for 20 s and 
was then moved from the maze to its home cage. If the mouse did not find 
the platform within 60 s, it was manually placed on the platform and re-
turned to its home cage after 20 s. The inter-trial interval for each mouse was 
5 min. On day 5, the platform was removed from the pool, and each mouse 
was tested by a probe trial for 60 s. On days 6 and 7, the platform was placed 1078 Meningeal immunity in learning and memory | Derecki et al.
tissue was washed three times with cold HBSS by resuspending the tissue and 
pelleting in a 4°C centrifuge. To obtain a single-cell suspension, the tissue 
was triturated gently by pipeting through a 5-ml serological pipette 20 times 
and then filtered through a 40-µm filter. These mixed glial cells were cul-
tured to 85% confluence with culture medium consisting of DMEM/F12 
with 10% fetal bovine serum, 1% glutamine, 1% amphotericin B, and 1% 
penicillin/streptomycin in a 5% CO2/37°C incubator before passage. To 
obtain purified astrocytes, flasks were rinsed with DMEM before media 
changes (every 2 d for the first week) to eliminate nonadherent cells. Cul-
tures were passaged once a week at least three times before use in co-culture 
experiments. Cells were passaged by rinsing two times with PBS and incu-
bated for 3 min in 2.5% trypsin-EDTA in a 5% CO2/37°C incubator. The 
supernatants were collected, spun at 1,200 rpm for 5 min, and washed two 
times by resuspending the cells and centrifuging at 4°C. Cell pellets were   
resuspended in culture medium and seeded at 106 cells/ml onto 24-well inserts 
(106 cells/well; 1-µm Falcon; BD) or 8 × 106 cells/ml in a 75-ml flask.   
Astrocytes were incubated with the cytokines indicated in the figures at dif-
ferent concentrations (10 ng/ml is the most effective dose and is presented in 
the results) for 12 h before RNA was isolated. J. Mandell (University of   
Virginia, Charlottesville, VA) and his laboratory members provided us with   
primary astrocytes for the initial experiments.
qRT-PCR
Total cellular RNA was isolated by using Tri Reagent (Applied Biosys-
tems) according to the manufacturer’s instructions. RNA was treated with 
TurboDNase (Applied Biosystems) according to the manufacturer’s instruc-
tions, and cDNA was obtained by using a high-capacity cDNA Archive Kit 
(Applied Biosystems), according to the manufacturer’s instructions, using 
500 ng mRNA per sample. Mice were anesthetized with nembutal and 
transcardially perfused with 0.1 M PBS, pH 7.4. Heads were removed im-
mediately and kept on ice. Meninges were removed as described in FACS 
of meningeal isolates. Hippocampi were dissected. All dissected tissue was 
placed into ice-cold RNAlater (Applied Biosystems). Total hippocampal 
RNA was isolated using Tri Reagent and treated with DNase I (Roche), 
all according to the manufacturer’s instructions. Using 500 ng mRNA per 
sample, RNA was reverse transcribed using the iScript cDNA Synthesis 
Kit with an iCycler and subjected to qRT-PCR using the iQ5 Real-Time 
Detection System (all from Bio-Rad Laboratories). Samples were used to 
amplify TNF (forward primer, 5-TCTTCTCATTCCTGCTTGTG-3; 
reverse primer, 5-ACTTGGTGGTTTGCTACG-3) and BDNF (forward 
primer, 5-CGGTACAGTTGGCCTTTGGATACCG-3; reverse primer, 
5-GTGGGTCACAGCGGCAGATA-3).  -glucoronidase  was  used  as  a 
control for all samples (forward primer, 5-ACCAGCCACTATCCCTAC-3; 
reverse primer, 5-ACAGACCACATCACAACC-3), and the concen-
tration of gene transcripts was determined relative to the concentration of   
-glucoronidase. All primers were validated in house by analyzing product 
length by gel electrophoresis. Amplification of TNF, BDNF, and -glucoronidase 
was performed in triplicate using a reaction mixture of 5 µl of synthesized 
cDNA product, 12 µl SYBR Green SensiMix (Quantace), primers (0.5 µl 
each of 10-nm stock), and 7 µl of RT-PCR–grade water (Applied Bio-
systems) to a total volume of 25 µl. The real-time thermocycler protocol   
(iQ5 Real Time Detection System) began with a single preincubation (95°C 
for 3 min), followed by 40 amplification cycles of 95°C for 10 s and 55°C 
for 30 s, with a single fluorescence reading at the end of each amplification 
step. Melt curves were generated for each well, and samples demonstrating 
melt curves indicating amplification of a nonspecific product or incorrect 
melt temperature were discarded.
Online supplemental material
Fig. S1 shows that peripheral lymphopenia is induced by FTY720 treat-
ment. Fig. S2 shows impaired performance of IL-4/ mice in the reverse 
phase of the MWM spatial learning and memory task. Fig. S3 shows 
no difference in brain gross histology between wild-type and IL-4/ 
mice. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20091419/DC1.
buffer. Cells were stained for extracellular markers with antibodies to 
CD11b conjugated to FITC or PE; CD45 conjugated to allophycocyanin 
(APC), APC-Cy7, or efluor 450; CD3 conjugated to efluor 450, FITC, or 
Alexa Fluor 780; CD4 conjugated to FITC, PE, APC, or efluor 450; CD8 
conjugated to FITC or PE; CD62L conjugated to PE; CD44 conjugated to 
FITC; CCR7 conjugated to PE-Cy7; or CD69 conjugated to PE-Cy7 or 
PE. Cells were stained for intracellular markers with antibodies to IL-12 
conjugated to PerCP Cy5.5, TNF conjugated to PE, IL-4 conjugated to 
PE or PE-Cy7, or IFN- conjugated to PE-Cy7 (eBioscience). For IL-4 
and  IFN-  staining,  meningeal  isolates  were  incubated  with  10  µg/ml 
brefeldin A at 37°C for 5 h and labeled with the appropriate antibodies as 
described (eBioscience). All cells were fixed in 1% paraformaldehyde in 
0.1 M PBS, pH 7.4. Fluorescence data were collected with a CyAn ADP 
High-Performance Flow Cytometer (Dako) and analyzed using Flowjo 
software (Tree Star, Inc.). To obtain equivalent and accurate cell counts, 
cells were gated first using the LIVE/DEAD Fixable Dead Cell Stain Kit 
according to the manufacturer’s instructions (Invitrogen), forward versus 
side scatter to eliminate debris, pulse width versus area to select singlet cells, 
and then by appropriate markers for cell type (e.g., CD11b for myeloid-
derived cells or CD3 for T cells). All histograms for CD11b cells depict 
comparisons of 3–10 × 103 cells for each sample.
CD4+ and CD8+ meningeal T cell counts by FACS
Pooled  single-cell  suspensions  from  four  mice  (either  naive  or  MWM 
trained) were prepared and stained for the appropriate markers, as described 
in the previous section. Cells were collected with a high-performance flow 
cytometer (CyAn ADP; Beckman Coulter). Equivalent numbers of CD45+ 
cells were used to arrive at relative CD3+CD4+ and CD3+CD8+ numbers 
for each pool. These counts were divided by the number of mice used to 
prepare the pooled sample (n = 4) and multiplied by the number of samples 
obtained for staining from each pool, thus yielding an estimate of CD3+CD4+ 
and  CD3+CD8+  cells  from  each  mouse  meninges.  Experiments  were   
repeated three times, and groups were compared using ANOVA.
Floating section immunohistochemistry
Free-floating sections were incubated with 10% normal serum for 1 h at 
room  temperature  in  TBS  containing  0.3%  Triton  X-100,  followed  by   
incubation with appropriate dilutions of the primary antibodies for 24–48 h 
at 4°C in the same buffer. Sections were washed for 5 min three times at 
room temperature, followed by incubation with Alexa Fluor 488 or 594 
chicken/goat anti–mouse/rat IgG antibodies (1:1,000; Invitrogen) for 1 h 
at room temperature. Sections were washed again with TBS (5 min three 
times) and mounted with Aqua-Mount (Lerner Laboratories) under cover-
slips. For examination of meningeal cells, 40-µm sections through the ante-
rior and posterior limits of the lateral ventricle, starting at a random anterior 
point before the opening of the ventricle and ending at its closing, were pro-
cessed and counted by two independent observers blinded to group.
Giemsa staining
20-µm frozen mounted sections were rinsed/rehydrated for 1 min in dis-
tilled water (dH2O) at room temperature; incubated in Giemsa solution 
(40 drops of stock solution [Bio-Rad Laboratories] in 40 ml dH2O) for 
30 min at 60°C; dipped five times briefly in tap water at room temperature; 
dipped five times briefly in 1% acetic acid; dipped five times each, succes-
sively, in 70, 95, 95, and 100% ethanol; cleared for 3 min three times in 
xylene; and mounted and coverslipped using Cytoseal 60 (Richard Allan 
Scientific). Images were taken at 100, 400, and 800× and compared by a 
blinded observer.
Astrocyte primary culture
Mouse astrocyte cultures were prepared from 1-d-old mouse neonates as 
follows. Brains were excised and placed in ice-cold HBSS. Neocortical tissue 
was removed and minced by passage through a 5-ml plastic pipette. The cell 
suspension was incubated in 0.25% trypsin at 37°C for 30 min. After adding 
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